The federally funded COVID-19 Prevention Network was instrumental in the rapid development of safe, effective and lifesaving COVID-19 vaccines during earlier phases of the pandemic. This vital work to expedite Phase 3 clinical trials also resulted in a ‘treasure trove’ of data, thanks to a highly collaborative and harmonized approach that can serve as a national and even international model for major research initiatives while also guiding responses to future public health emergencies.
Individuals who, despite having been vaccinated against COVID-19, develop the disease and are hospitalized are less likely to go to an intensive care unit (ICU), more likely to have a shorter hospital stay, and less likely to die in the hospital than individuals hospitalized for COVID who were never vaccinated, according to a national study from the Centers for Disease Control and Prevention’s VISION Network.
SARS-CoV-2 vaccines protected infant rhesus macaques against 1 severe lung disease after high dose challenge one year after vaccination.
The Delta variant of SARS-CoV-2 has swept the globe, becoming the dominant variant within just a few months.
Two new studies presented today at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo reveal how antibodies against the SARS-CoV-2 virus can vary among recipients of different COVID-19 vaccines and naturally infected individuals. The findings provide critical data about the immune response to COVID-19 vaccines that could inform future diagnostic research and vaccination efforts.
New UCLA-led research indicates that simple text messages emphasizing the easy availability of COVID-19 vaccines successfully boosted the number of people who got the shot.
The COVID-19 vaccine is your best defense against the virus, but when and where should you continue to wear a mask? Rush infectious disease expert Michael Lin, MD, answers questions about wearing a mask post-vaccination.
Rush system hospitals now have few or no patients with COVID-19 as vaccines’ impact increases.
National Comprehensive Cancer Network’s patient information team provides a patient and caregiver version of recently-updated, evidence-based expert consensus recommendations for vaccinating people with cancer against COVID-19.
Reynold Panettieri, vice chancellor for translational medicine and science at Rutgers University, and Stanley H. Weiss, an epidemiologist and professor at the Rutgers New Jersey Medical School and the Rutgers School of Public Health, are available to discuss the possibility…
A single dose of the Pfizer-BioNTech vaccine for individuals who previously had COVID-19 generates an immunologic response similar to that of individuals receiving the two-dose recommended sequence, according to a Cedars-Sinai study published today by the journal Nature Medicine.
One year ago, then 65-year-old Miriam Clark developed a fever, lost her appetite and had no energy. She and her daughter, Tye Clark, the administrative services manager of the Johns Hopkins University School of Medicine Division of Hospital Medicine, never could have imagined what they would end up going through before Miriam was diagnosed with COVID-19. Looking back on the year, the mother and daughter duo are thankful and now even have reason to celebrate.
An update from the ACAAI COVID-19 Vaccine Task Force on the risk of allergic reactions to COVID-19 vaccines – including the Johnson & Johnson vaccine
The COVID-19 vaccines have been described by many as the light at the end of the tunnel and the best tool we have to stop this pandemic. But along with the vaccine rollout, there have been a number of myths circulating about their safety and effectiveness. To set the record straight, Cedars-Sinai’s Newsroom talked with Priya Soni, MD, a pediatrician and an infectious disease specialist.
As more people receive the COVID-19 vaccines, more people have questions about allergic reactions. Those questions are answered in this FAQ.
Staff, patient and community COVID-19 vaccine updates from Keck Medicine of USC
ACAAI COVID-19 Task Force updates guidance for physicians and other providers related to risk of an allergic reaction from mRNA COVID-19 vaccines.
On Dec. 17, a U.S. Food and Drug Administration panel is expected to review the data on the Moderna COVID-19 vaccine, paving the way for approval. Researchers at the George Washington University led one of the 100 clinical sites testing…
B-roll available: Video shot today showing the freezers where Cedars-Sinai will store COVID-19 vaccines. Please note: There are NO vaccines in the video. The vaccines will not arrive until next month.
UNLV researcher Edwin Oh and colleagues have implemented wastewater surveillance programs to screen samples for the presence of COVID-19 and to extract the RNA from the SARS-COV-2 virus to find targets that make vaccines more effective.